Akums Drugs and Pharmaceutical Asset Resilience Ratio

Latest as of March 2026: 23.78%

Akums Drugs and Pharmaceutical asset resilience ratio. Akums Drugs and Pharmaceutical (AKUMS) has an Asset Resilience Ratio of 23.78% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See AKUMS days of operational coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs12.95 Billion

≈ $140.05 Million USD Cash + Short-term Investments

Total Assets

Rs54.47 Billion

≈ $589.07 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio of Akums Drugs and Pharmaceutical (2022–2026)

Asset resilience ratio of Akums Drugs and Pharmaceutical from 2022 to 2026. This chart shows how Akums Drugs and Pharmaceutical's Asset Resilience Ratio has changed over time. Read debt load of Akums Drugs and Pharmaceutical for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Akums Drugs and Pharmaceutical's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see AKUMS asset base.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs12.95 Billion	23.78%
Total Liquid Assets	Rs12.95 Billion	23.78%

Asset Resilience Insights

Good Liquidity Position: Akums Drugs and Pharmaceutical maintains a healthy 23.78% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Akums Drugs and Pharmaceutical Industry Peers by Asset Resilience Ratio

Compare Akums Drugs and Pharmaceutical's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

Akums Drugs and Pharmaceutical Asset Resilience Ratio by Year (2022–2026)

Akums Drugs and Pharmaceutical asset resilience ratio by year from 2022 to 2026. The table below shows the annual Asset Resilience Ratio data for Akums Drugs and Pharmaceutical.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2026-03-31	23.78%	Rs12.95 Billion ≈ $140.05 Million	Rs54.47 Billion ≈ $589.07 Million	+12.09pp
2025-03-31	11.69%	Rs4.81 Billion ≈ $51.99 Million	Rs41.13 Billion ≈ $444.85 Million	+6.66pp
2024-03-31	5.03%	Rs1.77 Billion ≈ $19.12 Million	Rs35.16 Billion ≈ $380.28 Million	+2.00pp
2023-03-31	3.03%	Rs988.92 Million ≈ $10.69 Million	Rs32.67 Billion ≈ $353.26 Million	+1.46pp
2022-03-31	1.57%	Rs481.56 Million ≈ $5.21 Million	Rs30.69 Billion ≈ $331.91 Million	--

pp = percentage points

About Akums Drugs and Pharmaceutical

NSE:AKUMS India Drug Manufacturers - Specialty & Generic

Market Cap

$1.24 Billion

Rs115.06 Billion INR

Market Cap Rank

#7758 Global

#385 in India

Share Price

Rs751.50

Change (1 day)

-1.27%

52-Week Range

Rs414.05 - Rs823.30

All Time High

Rs1119.95